Get started
Author

Maria Alejandra Gonzalez Duarte Briseno

Observed names: Maria Alejandra Gonzalez-Duarte Briseno, Maria Alejandra González-Duarte Briseño
OpenAlex ID: A5000340588
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
2020 · David Adams, Michael Polydefkis, et al. · The Lancet Neurology · 159
Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update
2022 · Angela Dispenzieri, Teresa Coelho, et al. · Orphanet Journal of Rare Diseases · 87
Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis
2021 · Angelo Giuseppe Caponetti, Claudio Rapezzi, et al. · JACC Heart Failure · 79
Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
2021 · Jose Nativi-Nicolau, Alfonso Siu, et al. · JACC CardioOncology · 62
PDF
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy
2025 · David Adams, Jonas Wixner, et al. · JAMA Neurology · 40
PDF
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey
2023 · Juan González-Moreno, Angela Dispenzieri, et al. · Cardiology and Therapy · 25
Survival in a Contemporary, Real-World Cohort of Patients with Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: An Analysis from THAOS
2025 · Jonas Wixner, Angela Dispenzieri, et al. · Cardiology and Therapy · 9
PDF
Autonomic dysfunction and quality of life in a cohort of neurology outpatients with post-acute sequelae of COVID-19, a two-year follow-up study
2025 · Samarah Ahmed, Julia Greenberg, et al. · Journal of Clinical Neuroscience
Works count: 8
Citation count: 461
H-index: 7
I10-index: 6
Year
Topic
Type